Toxoplasmosis: Prevention, diagnosis and therapy in the pregnant woman, fetus and newborn infant;Toxoplasmosi: Prevenzione, diagnosi e terapia nella donna in gravidanza, nel feto e nel neonato

Rivista Italiana di Pediatria

Volumn 22, Issue 2, 1996, Pages 145-153

  Stronati, M ^a,b   Lanzarini, P ^a   Meroni, V ^a   Rondini, G ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Diagnosis; Prophylaxis; Therapy; Toxoplasmosis

Indexed keywords

EID: 2442498941     PISSN: 03925161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Koskiniemi M, Lappalainen M, Hedman K. Toxoplasmosis needs evaluation. AJDC 1989;143:726.
2. Couvreur J. Toxoplasmose Congenitale. Epidemiologie, physiopatologie, evolution, diagnostic, prognostic, principes du traitement, prevention. Rev Prat 1992;42:2.
3. Matsui D. Prevention, diagnosis and treatment of fetal toxoplasmosis. Clin Perinatol 1994;21:675.
4. Pedersen BS. Toxoplasmosis in pregnancy. Bailliere's Clin Obstet Gynaecol 1993;7:107.
5. Peckham CS, Logan S. Screening for toxoplasmosis during pregnancy. Arch Dis Child 1993;68:3.
6. Bale JF, Murph JR. Congenital infections and the nervous system. Pediatr Clin North Am 1992;39:669.
7. Foulon W. Congenital toxoplasmosis: Is screening desirable? Scand J Infect Dis 1992;84(Suppl.):11.
8. Baronciani D, Petrone M. Screening of toxoplasmosis during pregnancy. M & B 1994;4:211.
9. Thoumsin H, Senterre J, Lambotte R. Twenty-years screening for toxoplasmosis in pregnancy: Liege-Belgium. Scand J Infect Dis 1992;84(Suppl.):84.
10. Koskiniemi M, Lappalainen M, Koskela P, Hedman K, Ammala P, et al. The program for antenatal screening of toxoplasmosis in Finland: a prospective cohort study. Scand J Infect Dis 1992;84(Suppl.):70.
11. Foulon W, Naessens A, Derde MP. Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatol 1994;11:57.
12. Pedersen BS, Jenum P. Economic evaluation of preventive programmes against congenital toxoplasmosis. Scand J Infect 1992;84(Suppl.):86.
13. Carosi G, Carnevale G, Barcelle M, Castelli F, Maccabruni A, Benzi-Cipelli R. Epidemiologia delle infezioni connatali da agenti protozoari. Giornale di Malattie Infettive e Parassitarie 1983;35:1066.
14. Remington JS, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. Third Edition. Philadelphia: W.B. Saunders C. 1990:149.
15. Bagnoli F, Buffolano W, Carosi G, Castelli F, Colacurci N, et al. Raccomandazioni per la prevenzione, diagnosi, terapia prenatale e neonatale della toxoplasmosi. Bollettino SIMP 1994;1:4.
16. Fortier B, Ajana F, Pinto de Sousa MI, Aissi E, Camus D. Prevention et traitement de la toxoplasmose materno foetale. Press Med 1991;20:29.
17. Mirlesse V, Jacquemard F, Daffos F. Toxoplasmose au cours de la grossesse. Diagnostic et nouvelles possibilites therapeutiques. Press Med 1993;22:258.
18. Couvreur J. Toxoplasmose congenitale. Prevention. Surveillance. Traitement. Revue du Pediatre 1988;2:32.
19. Russo M, Galanti B. Prevenzione della toxoplasmosi congenita. Clin Ter 1990;134:383.
20. Forestier F, Daffos F, Hohlfeld P, Lynch L. Les foetopathies infectieuses. Prevention, diagnostic prenatal, attitude pratique. Press Med 1991;20:1448.
21. McCabe RE, Oster S. Current recommendations and failure prospects in the treatment of toxoplasmosis. Drugs 1989;38:973.
22. Piens MA, Garin JP. New perspectives in the chemoprophilaxis of toxoplasmosis. J Chemother 1989;1:46.
23. Garin JP, Mojon M, Piens MA, Chevalier-Nuttal I. Surveillance et traitement de la toxoplasmose chez la femme enceinte, le foetus et le nouveau-né. Pediatrie 1989;44:705.
24. Daffos F, Forestier F, Capella-Pavlosky M, Thulliez P, Aufraunt C, Valenti D, Cox WL. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988;318:271.
25. Hohlfeld P, Daffos F, Thulliez P, Aufrant C, Couvreur J, MacAleese J, Descombey D, Forestier F. Fetal toxoplasmosis: outcome of pregnancy and infant follow-up after in utero treatment. J Pediatr 1989;115:765.
26. Couvreur J, Thulliez P Daffos F, Aufrant C, Bompard Y, Gesquiere A, Desmonts G. Foetopatie toxoplasmique. Traitement in utero par l'association pyrimetamine-sulfamides. Arch Fr Pediatr 1991;48:397.
27. Stray-Pederson B. Treatment of toxoplasmosis in the pregnant mother and newborn child. Scand J Infect Dis 1992;84(Suppl.):23.
28. Webster LT Jr. Drugs used in the chemotherapy of protozoal infections: malaria. In: Goodman GA, Rall TW, Nies AS, et al. eds. The pharmacological basis of therapeutics. Eighth Edition. New York: Pergamon Press 1990:978
29. Guerina NG. Management strategies for infectious diseases in pregnancy. Semin Perinatol 1994;18:305.
30. Pedersen BS. New aspects of perinatal infections. Ann Med 1993;25:295.
31. Hall SM. Congenital toxoplasmosis. BMJ 1992;305:291.
32. Holliman RE. Toxoplasma gondii. In: Greenough A, Osborne J, Sutherland S, eds. Congenital perinatal and neonatal infections. Edinburgh: Churchill Livingstone 1992:209.
33. Foulon W, Naessens A, Mahaler T, De Waele M, De Catte L, De Meuter F. Prenatal diagnosis of congenital toxoplasmosis. Obstet Gynecol 1990;76:769.
34. Aspok H, Pollac A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis 1992;84(Suppl.):32.
35. Hengst P. Program in the Former «East»-Germany and the present status in Germany. Scand J Infect Dis 1992;84(Suppl.):38.
36. Stunzner D, Mayer HO, Mose JR. Toxoplasmosis: screening in pregnancy and surveillance of children born to mothers with acute infection. Hyg Med 1990;15:530.
37. Guerina NG. Congenital infection with Toxoplasma gondii. Pediatr Ann 1994;23:138.
38. Stronati M, Cerbo RM, Rondini G. Le infezioni congenite: profilassi e terapia. Riv Ital Pediatr 1995;21:135.
39. Guerina NG, Hsu-W, Meissner HC, et al. Neonatal serologic screening and early treatment of congenital Toxoplasma gondii infection. N Engl J Med 1994;330:1858.
40. Freij BJ, Sever JL. Toxoplasmosis. Pediatrics in Review 1991;12:227.
41. WHO publication WHO model prescribing information - Drugs used in parasitic disease. Geneva: WHO 1990:53.
42. Russo M. La toxoplasmosi in gravidanza. Prevenzione, diagnosi e terapia. Recenti Progressi in Medicina 1994;1:37.
43. Mombrò M, Perathoner C, Leone A, Nicocia M, Moiraghi Ruggenini A, Zotti C, Lievre MA, Fabris C. Congenital toxoplasmosis: 10-year follow up. Eur J Pediatr 1995;154:635.
44. Vaudaux B, Rudin C, Kind C, Schaad UB, Gnehm D, Nadal D, Suter S, Calame A, Hohlfeld P. Toxoplasmose congénitale: prise en charge pédiatrique. Schweiz Med Wochenschr 1995;125 (Suppl.65):70S.
45. Mombrò M, Perathoner C, Leone A, Nicocia M, Zotti C, Fabris C. Diagnosi, follow-up e terapia della toxoplasmosi connatale: descrizione di 11 casi. Riv Ital Pediatr 1994;20:717.
46. McAuley J, Boyer KM, Patel D, Mets M, Swisher C, et al. Early and longitudinal evaluations of treated infants and children and untreated historical patiens with congenital toxoplasmosis: the Chicago collaborative treatment trial. CID 1994;18:38.
47. Roizen N, Swiher CN, Stein MA, Hopkins J, Boyer KM, et al. Neurologic and development outcome in treated congenital toxoplasmosis. Pediatrics 1995;95:11.
48. Araujo FG, Remington JS. Antigenemia in recently acquired acute toxoplasmosis. J Infect Dis 1980;41:144.
49. Brooks RG, Sharma SD, Remington JS. Detection of Toxoplasma gondii antigens by a dot-immunobinding technique. J Clin Microbiol 1985;21:113.
50. Dupouy-Camet J, Laverada S, Bougnou,x et al. Preventing congenital toxoplasmosi. Lancet 1990;336:1018.
51. Grover CM, Thulliez P, Remington JS, Boothroyd JC. Rapid prenatal diagnosis of congenital toxoplasma infection by using polymerase chain reaction and amniotic fluid. J Clin Microbiol 1990;28:2297.
52. McCabe R, Chiarugi V. Issue in toxoplasmosis. Inf Dis Clin North Am 1993;7:587.
53. Thulliez P. Reliability of PCR in respect of conventional methods. N Engl J Med 1994;695.
54. Filice G, Carnevale G, Meroni V, Olliaro P, Lanzarini P, Carosi G, Rondanelli EG. Toxoplasmosi. Diagnostica e prevenzione della toxoplasmosi connatale. Milano: Wichting Editore 1985.
55. Walton BC, Benchoff BM, Brooks WH. Comparison of indirect fluorescent antibody test and methylen blue dye test for detection of antibodies to Toxoplasma gondii. Am J Trop Med Hyg 1966;15:149.
56. Fulton JD, Turk JL. Direct agglutination test for Toxoplasma gondii. Lancet 1959;11:1068.
57. Jacobs L, Lunde M. A hemagglutination test for toxoplasmosis. J Parasitol 1957;43:308.
58. Carlier Y, Bout D, Dessaint JP, et al. Evaluation of the enzyme-linked immunosorbent assay (ELISA) and other serological tests for the diagnosis of toxoplasmosis. Bull WHO 1980;58:99.
59. Warren J, Sabin AB. The complement fixation reaction in toxoplasmic infection. Proc Soc Exp Biol Med 1942;51:11.
60. Sabin AB, Feldman HA. Dye as microchemical indicators of a new immunity phenomenon affecting a protozoan parasite (Toxoplasma). Science 1948;108:660.
61. Lappalainen M, Koskela P, Koskiniemi M, Ammala P, Hiilesmaa V, Teramo K, O Raivio K, Remington JS, Hedman K. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. J Infect Dis 1993;167:691.
62. Naot Y, Desmonts G, Remington JS. IgM enzyme-linked immunosorbent assay for the diagnosis of congenital Toxoplasma infection. J Pediatr 1981;98:32.
63. Desmonts G, Naot Y, Remington JS. Immunoglobulin M-immunosorbent agglutination assay for diagnosis of infectious diseases: diagnosis of acute congenital and acquired Toxoplasma infections. J Clin Microbiol 1981;14:486.
64. Decoster A, Darcy F, Caron A, Capron A. IgA antibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet 1988ii:1104.
65. Pinon JM, Thoannes H, Pouletty PH, Poirriez J, Damiens J, Pellettier P. Detection of IgA specific for toxoplasmosis in serum and cerospinal fluid using a non-enzymatic IgA-capture assay. Diagn Immunol 1986;4:223.
66. Stepick-Biek P, Thulliez P, Arauju FG, Remington JS. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis 1990;162:270.